San Francisco, CA, United States of America

William Grossman

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Grossman. Retrieved from https://idiyas.com/inventor/william-grossman-m75pgwq4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Grossman

Introduction

William Grossman is a notable inventor based in San Francisco, CA. He has made significant contributions to the pharmaceutical industry, particularly through his innovative work at Merck & Co., Inc. His expertise in drug formulation has led to the development of important medical compositions.

Latest Patents

William Grossman holds a patent for the composition of enalapril and losartan. This invention discloses a pharmaceutical composition that combines these two compounds with a pharmaceutically acceptable carrier. His work in this area has the potential to improve treatment options for patients with specific health conditions.

Career Highlights

Throughout his career, Grossman has been dedicated to advancing pharmaceutical science. His role at Merck & Co., Inc. has allowed him to collaborate with other talented professionals in the field. His innovative approach to drug development has earned him recognition within the industry.

Collaborations

William Grossman has worked alongside esteemed colleagues such as Kenneth A. Krammer and Charles S. Sweet. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

William Grossman is a distinguished inventor whose contributions to pharmaceutical compositions have made a significant impact. His work continues to influence the field and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…